Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia

NCT00895297 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

NETWORK

Sponsor class

Stopped Slow recruitment. No safety concerns during this study.

Conditions

Chronic Myeloid Leukemia

Interventions

DRUG: Dasatinib (Sprycel)

Sponsor

European Society for Blood and Marrow Transplantation

Collaborators

[object Object]